MAR 12, 2016 10:46 AM PST

Test Reveals Some Breast Cancer Patients Don't Need Chemo

WRITTEN BY: Xuan Pham
Chemotherapy is aggressive poisoning of rogue cells to cure cancer. But do all cancer patients benefit from this therapy? According to recent results of a new genetic test for breast cancer, the answer is no.
 
Genetic test reveals chemo is not necessary for all breast cancer patients

The test, called Oncotype DX, can identify patients in whom the breast cancers are more likely to be dormant. These women can thus be spared the agony of chemotherapy in favor of the less intense hormone therapy. Among the group of women that the test predicted to be at low risk for cancer recurrence, researchers reported 94% were alive and cancer-free at the five-year mark.
 
The Oncotype DX test is formally known as the 21-gene Recurrence Score assay. It works by analyzing the activity of 21 genes involved with breast cancer aggression and how these tend to respond after treatment. The outputs are scores that range from 0-100, with higher scores indicating worse prognoses.
 
In the study, German researchers recruited nearly 3,200 women with non-metastatic breast cancer that was also estrogen receptor positive and HER2 negative. About 15% of the women scored from 0-11, and were deemed at low recurrence risk even if other factors suggested otherwise; these patients received anti-hormonal therapies only. Of these women whose testing spared them of chemotherapy, 94% were living disease-free five years after their diagnoses.
 
Meanwhile, patients who scored between 12-25 were randomly assigned to one of two different chemotherapy treatments. These patients showed the same disease-free survival rates of 94% when treated with chemotherapy. Patients who scored above 25 received the same chemotherapy treatments and had 84% recurrence rate.
 
"These tests are able to define a substantial proportion of patients with very low recurrence risk who would not benefit from chemotherapy," said Oleg Gluz, first study author. In these women, skipping chemotherapy was the right call, as hormone therapy seemed to have nearly the same effect on cancer recurrence but without the damaging side effects.

Following the ideas of precision medicine, the Oncotype DX test is a new way to tailor treatments to individual breast cancer patients. Knowing those who will or will not benefit from grueling chemotherapy could save many patients from unnecessary side effects and costly treatments.
 
Although the results of this five-year study are promising and consistent with its three-year reports, some are still waiting on the survival rates at the 10-year mark. Genomic Health, the company that makes Oncotype DX, is already getting started on this follow-up study, and has plans to enroll more patients for other new combination therapy trials.
 

Additional source: US News Health
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
MAR 23, 2020
Genetics & Genomics
MAR 23, 2020
Diagnosing Cancer by Looking for Microbial DNA in the Blood
Liquid biopsies aim to diagnose a disease with only a bit of biological fluid, usually blood.
APR 13, 2020
Cancer
APR 13, 2020
The Unexpected Role of Mono in Cancer Progression
In the past, the go-to drugs have always been small molecules. These small molecules would interact with the cell and ac ...
APR 16, 2020
Genetics & Genomics
APR 16, 2020
A New Way to Quickly Test for COVID-19
Some of the reagents used in popular diagnostic tests may be in short supply, so other testing methods will be needed.
APR 29, 2020
Clinical & Molecular DX
APR 29, 2020
Move and Detect : Diagnosis of Neonatal Sepsis Using Fluorescent Micromotors
According to the World Health Organization (WHO), sepsis occurs when the body’s response to an infection injures i ...
JUN 08, 2020
Microbiology
JUN 08, 2020
Concerns Remain About the Accuracy of COVID-19 Tests
Diagnostic tests have recently been getting a lot of attention because of the COVID-19 pandemic.
JUN 16, 2020
Clinical & Molecular DX
JUN 16, 2020
Don't Sweat It! New Tech Monitors Health With a Single Drop of Sweat.
Looking for ways to cool off and beat the summer heat? Think twice before wiping that sweat off your brow. Every drop of ...
Loading Comments...